Angiogenesis PET Tracer Uptake ((68)Ga-NODAGA-E[(cRGDyK)]₂) in Induced Myocardial Infarction in Minipigs.
Angiogenesis is part of the healing process following an ischemic injury and is vital for the post-ischemic repair of the myocardium. Therefore, it is of particular interest to be able to noninvasively monitor angiogenesis. This might, not only permit risk stratification of patients following myocardial infarction, but could also facilitate development and improvement of new therapies directed towards stimulation of the angiogenic response. During angiogenesis endothelial cells must adhere to one another to form new microvessels. αvβ₃ integrin has been found to be highly expressed in activated endothelial cells and has been identified as a critical modulator of angiogenesis. (68)Ga-NODAGA-E[c(RGDyK)]₂ (RGD) has recently been developed by us as an angiogenesis positron-emission-tomography (PET) ligand targeted towards αvβ₃ integrin. In the present study, we induced myocardial infarction in Göttingen minipigs. Successful infarction was documented by (82)Rubidium-dipyridamole stress PET and computed tomography. RGD uptake was demonstrated in the infarcted myocardium one week and one month after induction of infarction by RGD-PET. In conclusion, we demonstrated angiogenesis by noninvasive imaging using RGD-PET in minipigs hearts, which resemble human hearts. The perspectives are very intriguing and might permit the evaluation of new treatment strategies targeted towards increasing the angiogenetic response, e.g., stem-cell treatment.
Department of Clinical Physiology, Nuclear Medicine &amp; PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. drrasmussen@hotmail.com.
Thomas
T
Rasmussen
Cardiology Stem Cell Centre, Department of Cardiology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. bjarke.follin.larsen@regionh.dk.
Bjarke
B
Follin
Cardiology Stem Cell Centre, Department of Cardiology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. jens.kastrup@regionh.dk.
Jens
J
Kastrup
Department of Clinical Physiology, Nuclear Medicine &amp; PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. malene.brandt-larsen@regionh.dk.
Malene
M
Brandt-Larsen
Department of Clinical Physiology, Nuclear Medicine &amp; PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. jacob.madsen@regionh.dk.
Jacob
J
Madsen
Department of Clinical Physiology, Nuclear Medicine &amp; PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. thomas.emil.christensen@regionh.dk.
Thomas
T
Emil Christensen
Department of Experimental Medicine, University of Copenhagen, Blegdamsvej 3B, 2100 Copenhagen, Denmark. kah@sund.ku.dk.
Karsten
K
Pharao Hammelev
Department of Clinical Physiology, Nuclear Medicine &amp; PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. philip.hasbak@regionh.dk.
Philip
P
Hasbak
Department of Clinical Physiology, Nuclear Medicine &amp; PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. andreas.kjaer@regionh.dk.
Andreas
A
Kjær
angiogenesis; myocardial infarction; positron-emission-tomography